| Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017 | 183 | 2017 |
| Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ... Expert review of clinical pharmacology 8 (1), 77-94, 2015 | 144 | 2015 |
| Personalizing health care: feasibility and future implications B Godman, AE Finlayson, PK Cheema, E Zebedin-Brandl, ... BMC medicine 11 (1), 1-23, 2013 | 114 | 2013 |
| Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs RE Malmström, BB Godman, E Diogene, C Baumgärtel, M Bennie, ... Frontiers in pharmacology 4, 39, 2013 | 107 | 2013 |
| A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish … L McCullagh, L Tilson, C Walsh, M Barry Pharmacoeconomics 27 (10), 829-846, 2009 | 90 | 2009 |
| Payers' views of the changes arising through the possible adoption of adaptive pathways M Ermisch, A Bucsics, P Vella Bonanno, F Arickx, A Bybau, T Bochenek, ... Frontiers in pharmacology 7, 305, 2016 | 63 | 2016 |
| Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV‐coinfected individuals* S Hopkins, J Lambourne, G Farrell, L McCullagh, M Hennessy, S Clarke, ... HIV medicine 7 (4), 248-254, 2006 | 36 | 2006 |
| The pharmacoeconomic evaluation process in Ireland L McCullagh, M Barry Pharmacoeconomics 34 (12), 1267-1276, 2016 | 25 | 2016 |
| Identifying and revealing the importance of decision-making criteria for health technology assessment: a retrospective analysis of reimbursement recommendations in Ireland S Schmitz, L McCullagh, R Adams, M Barry, C Walsh PharmacoEconomics 34 (9), 925-937, 2016 | 24 | 2016 |
| General practitioners’ views on malnutrition management and oral nutritional supplementation prescription in the community: a qualitative study PD Castro, CME Reynolds, S Kennelly, B Clyne, G Bury, D Hanlon, ... Clinical nutrition ESPEN 36, 116-127, 2020 | 23 | 2020 |
| Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting L McCullagh, C Walsh, M Barry Pharmacoeconomics 30 (10), 941-959, 2012 | 22 | 2012 |
| The cost of the inpatient management of febrile neutropenia in cancer patients–a micro‐costing study in the I rish healthcare setting C O'Brien, E Fogarty, C Walsh, O Dempsey, M Barry, MJ Kennedy, ... European journal of cancer care 24 (1), 125-132, 2015 | 16 | 2015 |
| Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study K Cardwell, SM Smith, B Clyne, L McCullagh, E Wallace, C Kirke, T Fahey, ... BMJ open 10 (6), e035087, 2020 | 15 | 2020 |
| Supporting prescribing in Irish primary care: protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care K Cardwell, B Clyne, F Moriarty, E Wallace, T Fahey, F Boland, ... Pilot and feasibility studies 4 (1), 1-11, 2018 | 15 | 2018 |
| Economic evaluation of systemic treatments for advanced melanoma: a systematic review C Gorry, L McCullagh, M Barry Value in Health 23 (1), 52-60, 2020 | 14 | 2020 |
| An investigation of community-dwelling older adults' opinions about their nutritional needs and risk of malnutrition; a scoping review PD Castro, CME Reynolds, S Kennelly, AA Geraghty, K Finnigan, ... Clinical Nutrition 40 (5), 2936-2945, 2021 | 10 | 2021 |
| Coronavirus disease 2019: considerations for health technology assessment from the National Centre for Pharmacoeconomics Review Group J Leahy, C Hickey, D McConnell, O Cassidy, L Trela-Larsen, M Barry, ... Value in Health 23 (11), 1423-1426, 2020 | 10 | 2020 |
| Characteristics and determinants of high volume dispensing in long-term oral nutritional supplement users in primary care: a secondary analysis PD Castro, C Reynolds, MG Bizzaro, S Kennelly, B Clyne, G Bury, ... BJGP open 5 (2), 2021 | 7 | 2021 |
| Neoadjuvant treatment for malignant and metastatic cutaneous melanoma C Gorry, L McCullagh, H O'Donnell, S Barrett, S Schmitz, M Barry, K Curtin, ... The Cochrane Database of Systematic Reviews 2018 (3), 2018 | 7 | 2018 |
| The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting RB Morgan, L McCullagh, M Barry, C Daly Irish Journal of Medical Science (1971-) 186 (2), 293-303, 2017 | 7 | 2017 |
